Cargando…

Advancing Toward HIV-1 Vaccine Efficacy through the Intersections of Immune Correlates

Interrogating immune correlates of infection risk for efficacious and non-efficacious HIV-1 vaccine clinical trials have provided hypotheses regarding the mechanisms of induction of protective immunity to HIV-1. To date, there have been six HIV-1 vaccine efficacy trials (VAX003, Vaxgen, Inc., San Fr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tomaras, Georgia D., Haynes, Barton F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053939/ https://www.ncbi.nlm.nih.gov/pubmed/24932411 http://dx.doi.org/10.3390/vaccines2010015

Ejemplares similares

The immune response during acute HIV-1 infection: clues for vaccine development
por: McMichael, Andrew J., et al.
Publicado: (2009)

Humoral and Innate Antiviral Immunity as Tools to Clear Persistent HIV Infection
por: Ferrari, Guido, et al.
Publicado: (2017)

Bringing the path toward an HIV-1 vaccine into focus
por: Lopez Angel, Cesar J., et al.
Publicado: (2020)

Correlation Between Anti-gp41 Antibodies and Virus Infectivity Decay During Primary HIV-1 Infection
por: Vaidya, Naveen K., et al.
Publicado: (2018)

Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection risk
por: Andersen-Nissen, Erica, et al.
Publicado: (2021)

The Landscape of Targeted Immune Responses in the HIV-1 Vaccine Field
por: Safrit, Jeffrey T., et al.
Publicado: (2016)

SARS-CoV-2 and HIV-1 — a tale of two vaccines
por: Haynes, Barton F.
Publicado: (2021)

Publisher Correction: SARS-CoV-2 and HIV-1 — a tale of two vaccines
por: Haynes, Barton F.
Publicado: (2021)

Author Correction: SARS-CoV-2 and HIV-1 – A Tale of Two Vaccines
por: Haynes, Barton F.
Publicado: (2021)

P04-48. HIV-1 envelope induces memory B cell responses that correlate with plasma antibody levels after gp120 protein vaccination or chronic HIV-1 infection
por: Bonsignori, M, et al.
Publicado: (2009)

Immune System Regulation in the Induction of Broadly Neutralizing HIV-1 Antibodies
por: Kelsoe, Garnett, et al.
Publicado: (2013)

HIV-1 gp120 and Modified Vaccinia Virus Ankara (MVA) gp140 Boost Immunogens Increase Immunogenicity of a DNA/MVA HIV-1 Vaccine
por: Shen, Xiaoying, et al.
Publicado: (2017)

HIV mRNA Vaccines—Progress and Future Paths
por: Mu, Zekun, et al.
Publicado: (2021)

HIV-1 Envelope gp41 Broadly Neutralizing Antibodies: Hurdles for Vaccine Development
por: Verkoczy, Laurent, et al.
Publicado: (2014)

Improving Defences at the Portal of HIV Entry: Mucosal and Innate Immunity: A summary report from a Global HIV Vaccine Enterprise Working Group
por: Shattock, Robin J, et al.
Publicado: (2008)

Vaccine-Induced IgG Antibodies to V1V2 Regions of Multiple HIV-1 Subtypes Correlate with Decreased Risk of HIV-1 Infection
por: Zolla-Pazner, Susan, et al.
Publicado: (2014)

HIV-1 Specific IgA Detected in Vaginal Secretions of HIV Uninfected Women Participating in a Microbicide Trial in Southern Africa Are Primarily Directed Toward gp120 and gp140 Specificities
por: Seaton, Kelly E., et al.
Publicado: (2014)

Analysis of V2 Antibody Responses Induced in Vaccinees in the ALVAC/AIDSVAX HIV-1 Vaccine Efficacy Trial
por: Zolla-Pazner, Susan, et al.
Publicado: (2013)

Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial
por: Gottardo, Raphael, et al.
Publicado: (2013)

Selection of HIV Envelope Strains for Standardized Assessments of Vaccine-Elicited Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies
por: Mielke, Dieter, et al.
Publicado: (2022)

Progress with induction of HIV broadly neutralizing antibodies in the Duke Consortia for HIV/AIDS Vaccine Development
por: Haynes, Barton F., et al.
Publicado: (2023)

The quest for vaccine-induced immune correlates of protection against tuberculosis
por: Nemes, Elisa, et al.
Publicado: (2022)

Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus Macaques
por: Negri, Donatella, et al.
Publicado: (2016)

Structure and Diversity of the Rhesus Macaque Immunoglobulin Loci through Multiple De Novo Genome Assemblies
por: Ramesh, Akshaya, et al.
Publicado: (2017)

Intersection of HIV and Reproductive Health
por: Cohen, Craig R., et al.
Publicado: (2013)

Human gut microbiota is associated with HIV-reactive immunoglobulin at baseline and following HIV vaccination
por: Cram, Jacob A., et al.
Publicado: (2019)

The transcription factor CREB1 is a mechanistic driver of immunogenicity and reduced HIV-1 acquisition following ALVAC vaccination
por: Tomalka, Jeffrey Alan, et al.
Publicado: (2021)

Antibody‐virus co‐evolution in HIV infection: paths for HIV vaccine development
por: Bonsignori, Mattia, et al.
Publicado: (2017)

THE INTERSECTION OF ETHICS AND VULNERABLE ELDERS
por: Teaster, Pamela B, et al.
Publicado: (2019)

A New Vaccine to Battle Covid-19
por: Haynes, Barton F.
Publicado: (2020)

Coping with Viral Diversity in HIV Vaccine Design: A Response to Nickle et al
por: Fischer, Will, et al.
Publicado: (2008)

Isolation of HIV-1-Neutralizing Mucosal Monoclonal Antibodies from Human Colostrum
por: Friedman, James, et al.
Publicado: (2012)

Innovation at the Intersection of Alcohol and HIV Research
por: van Heerden, Alastair, et al.
Publicado: (2017)

INTERSECTIONAL DIFFERENCES IN HEALTHY AGING WITH HIV
por: Taylor, Tonya N
Publicado: (2019)

IDLV-HIV-1 Env vaccination in non-human primates induces affinity maturation of antigen-specific memory B cells
por: Blasi, Maria, et al.
Publicado: (2018)

HIV-1 vaccination by needle-free oral injection induces strong mucosal immunity and protects against SHIV challenge
por: Jones, Andrew T., et al.
Publicado: (2019)

Structural and genetic convergence of HIV-1 neutralizing antibodies in vaccinated non-human primates
por: Cai, Fangping, et al.
Publicado: (2021)

HLA class II-Restricted CD8+ T cells in HIV-1 Virus Controllers
por: Nyanhete, Tinashe E., et al.
Publicado: (2019)

Single-cell analysis of immune cell transcriptome during HIV-1 infection and therapy
por: Pollara, Justin, et al.
Publicado: (2022)

Advances in HIV-1 Vaccine Development
por: Gao, Yong, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1pgac7c5954gcljrp7rhashh4v